Categories AlphaGraphs, Earnings, Health Care

Mylan stock tanks on Q4 earnings miss; issues full-year guidance

Shares of Mylan NV (MYL) fell sharply Tuesday after the specialty pharmaceuticals company reported a decline in its fourth-quarter earnings which also missed analysts’ estimates. Though revenue decreased, it came in above expectations. The company also provided earnings and revenue guidance for fiscal 2019.

Mylan Q4 earnings fall
Mylan Q4 2018 Earnings Infographic

Adjusted earnings declined 9% to $1.30 per share during the three-month period and missed market estimates. Reported profit was $51.2 million or $0.10 per share, compared to $244.3 million or $0.46 per share in the fourth quarter of 2017.

Revenues dropped 5% annually to $3.08 billion, hurt mainly by a decline in the sale of existing products. The top-line, meanwhile, exceeded the Wall Street forecast. During the quarter, a 1 % revenue growth in Europe and 4% increase in the rest of the world were more than offset by a 16% fall in the North American market, continuing the recent trend.

Revenues dropped 5% annually to $3.08 billion, hurt mainly by a decline in the sale of existing products

“Looking forward, I can confidently say, through leveraging the diversification across our commercial, operational and scientific platforms, we feel incredibly positive about our ability to deliver a strong top-line financial performance in 2019,” said CEO Heather Bresch.

The company expects full-year 2019 adjusted earnings to be in the range of $3.80 per share to $4.80 per share. Revenues are currently forecast between $11.5 billion and $12.5 billion, which reflects growth across all geographical regions. The management is looking for adjusted free cash flow of $1.9-$2.3 billion for the year.

Related: Mylan Q3 profit beats estimates

Having secured several key regulatory approvals, required for the development and launch of products, the company expects overall performance to improve this year and beyond.

Mylan’s stock has been in a free fall for the past few years, after reaching a peak mid-2015. Since last year, the shares dropped about 25% and are hovering near the multi-year lows seen a few months ago. The stock plunged about 10% in Tuesday’s after-hours session following the earnings report.


Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Micron Earnings Preview: Recovery likely to continue as demand bounces back

Micron Technology Inc. (NASDAQ: MU), a market leader in memory and flash storage chips, emerged from a losing streak in the most recent quarter and reported a profit. The recovery

After mixed Q4, Darden Restaurants stays focused on profitable sales growth

Darden Restaurants, Inc. (NYSE: DRI), which owns popular restaurant brands Olive Garden and LongHorn Steakhouse, has reported stronger-than-expected fourth-quarter results, sending the stock higher soon after the announcement. Contributions from

What to expect when McCormick & Company (MKC) reports Q2 2024 earnings results

Shares of McCormick & Company, Incorporated (NYSE: MKC) stayed green on Friday. The stock has dropped 4% over the past one month. The spices and condiments maker is scheduled to report

Add Comment
Viewing Highlight